BIM
VNDA icon

BlackRock Investment Management’s Vanda Pharmaceuticals VNDA Stock Holding History

BlackRock Investment Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2.35M Sell
147,091
-666
-0.5% -$10.7K ﹤0.01% 2121
2016
Q3 		$2.46M Buy
147,757
+57
+0% +$767 ﹤0.01% 1987
2016
Q2 		$1.65M Sell
147,700
-2,299
-2% -$22.3K ﹤0.01% 2258
2016
Q1 		$1.25M Sell
149,999
-1,153
-0.8% -$9.46K ﹤0.01% 2338
2015
Q4 		$1.41M Buy
151,152
+743
+0.5% +$7.42K ﹤0.01% 2340
2015
Q3 		$1.7M Sell
150,409
-213
-0.1% -$2.6K ﹤0.01% 2196
2015
Q2 		$1.91M Buy
150,622
+46,903
+45% +$506K ﹤0.01% 2274
2015
Q1 		$965K Sell
103,719
-9,491
-8% -$107K ﹤0.01% 2540
2014
Q4 		$1.62M Buy
113,210
+13,875
+14% +$164K ﹤0.01% 2190
2014
Q3 		$1.03M Buy
99,335
+989
+1% +$13K ﹤0.01% 2505
2014
Q2 		$1.59M Buy
98,346
+6,469
+7% +$86.2K ﹤0.01% 2268
2014
Q1 		$1.49M Buy
91,877
+699
+0.8% +$9.94K ﹤0.01% 2235
2013
Q4 		$1.13M Sell
91,178
-1,993
-2% -$20K ﹤0.01% 2424
2013
Q3 		$1.02M Buy
93,171
+16,958
+22% +$181K ﹤0.01% 2433
2013
Q2 		$616K Buy
+76,213
New +$513K ﹤0.01% 2716

Other funds holding VNDA

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BlackRock Investment Management's VNDA Position: Q4 2016 in Review

BlackRock Investment Management reduced its Vanda Pharmaceuticals (VNDA) stake by 0.45% in Q4 2016, selling an estimated $10.7K and leaving 147,091 shares worth $2.35M. The position accounts for ﹤0.01% of the portfolio, ranked #2121.

BlackRock Investment Management first reported a position in VNDA in Q2 2013 and has held it in 15 quarters since. The position peaked at $2.46M in Q3 2016. 141 funds tracked by Wall St. Rank hold VNDA as of Q4 2016.

  • BlackRock Investment Management held 147,091 shares of Vanda Pharmaceuticals worth $2.35M as of Q4 2016.
  • BlackRock Investment Management sold 666 Vanda Pharmaceuticals shares in Q4 2016, an estimated $10.7K.
  • Vanda Pharmaceuticals made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2121 holding.
  • BlackRock Investment Management first reported a position in Vanda Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Investment Management's Vanda Pharmaceuticals position peaked at $2.46M in Q3 2016.
  • 141 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.